Tri-GalNAc(OAc)3 TFA

Tri-GalNAc(OAc)3 TFA

Tri-GalNAc(OAc)3 TFA is an intermediate in the synthesis of GalNAc-LYTAC with anticancer activity. GalNAc-LYTAC engages the asialoglycoprotein receptor (ASGPR) for targeted protein degradation. tri-GalNAc: triantenerrary N-acetylgalactosamine; LYTAC: Lysosome-Targeting Chimera.

Molecular structure of the compound BP-41316
    • Unit
    • Price
    • Qty
    • 50 MG
    • $540.00
    • 100 MG
    • $850.00
    • 250 MG
    • $1500.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire